Citations

Showing 10 of 108152 citations.

Involvement of the Cochlear Aqueduct by Jugular Paraganglioma Is Associated With Sensorineural Hearing Loss
Patel, Neil , Link, Michael J. , Driscoll, Colin L. W., Neff, Brian A., Lane, John I. , Carlson, Matthew L. , Gompel, Jamie J. Van

Mayo Clinic

Otology & Neurotology | August 30, 2019 | Volume: 40 | Issue: 9 | Pages: 1230-1236

10.1097/mao.0000000000002346 | PMID 31469795 Get It

Objective: The etiology of sensorineural hearing loss (SNHL) in patients with jugular paraganglioma (JP) whose tumors lack inner ear fistulae or vestibulocochlear nerve involvement is unknown. Recent literature has proposed that occlusion of the inferior cochlear vein may be causative. Herein, we assess the association between radiologic involvement of the cochlear aqueduct (CA) and the development of SNHL. Study Design: Blinded, retrospective review of imaging and audiometry. Setting: Tertiary center. Patients: Adults with JP. Intervention(s): None. Main Outcome Measures: Asymmetric SNHL was assessed continuously as the difference in bone conduction pure-tone average (BCPTA) between ears and as a categorical variable (≥15 dB difference at two consecutive frequencies, or a difference in speech discrimination score of ≥15%). Involvement of the CA was considered present if there was evidence of medial T2 fluid signal loss, contrast enhancement, or bony erosion/expansion. Results: Of 30 patients meeting inclusion criteria, 15 (50%) had asymmetric SNHL. CA involvement was observed in 87% of patients with asymmetric SNHL compared with 13% in those with symmetric hearing (p = 0.0001). Univariate analysis demonstrated that age, sex, and tumor volume were not associated with asymmetric SNHL. The median difference in BCPTA between ears in patients with CA involvement was 21.3 dB HL compared to 1.2 dB HL in those without CA involvement (p < 0.0001). Regression analysis demonstrates that enhancement within the CA is associated with a BCPTA difference of 19.4 dB HL (p = 0.0006). Conclusions: Cochlear aqueduct involvement by JP is associated with SNHL in the absence of inner ear fistula, vestibulocochlear nerve involvement, or brainstem compression. Correlation with operative findings or histopathologic evidence of tumor involvement may validate this intriguing imaging finding.
Delayed Tumor Growth in Vestibular Schwannoma: An Argument for Lifelong Surveillance
Macielak, Robert J. , Patel, Neil , Lees, Katherine A. , Lohse, Christine M. , Marinelli, John P. , Link, Michael J. , Carlson, Matthew L.

Mayo Clinic

Otology & Neurotology | August 30, 2019 | Volume: 40 | Issue: 9 | Pages: 1224-1229

10.1097/mao.0000000000002337 | PMID 31469794 Get It

Objective: Previous research has shown that tumor growth during observation of small-to-medium sized sporadic vestibular schwannomas (VSs) occurs almost exclusively within 3 to 5 years following diagnosis. This has led some to consider ending surveillance after this interval. This study seeks to characterize a cohort of patients with tumors that exhibited late growth. Study Design: Retrospective cohort study. Setting: Tertiary referral center. Patients: Adults with sporadic VSs who initially elected observation with serial magnetic resonance imaging (MRI) surveillance. Intervention(s): None. Main Outcome Measure(s): Linear tumor growth was measured in accordance with AAO-HNS reporting guidelines. Delayed growth was defined as growth ≥2 mm in linear diameter that was first detected 5 years or more from the initial MRI. Results: From a total of 361 patients, 172 experienced tumor growth during the interval of observation. Fourteen of these 172 patients (8.1%) experienced late growth occurring at 5 years or beyond. Among patients with delayed growth, the fastest growth rate after extended quiescence was 1.33 mm/yr, and the longest delay before tumor growth detection was 11.1 years. Additional treatment was recommended for six (42.9%) of the patients with delayed growth. Of 68 tumors that remained in the IAC, 11 (16.2%) demonstrated delayed growth. Of 66 tumors that presented in the CPA, 2 (3.0%) demonstrated delayed growth. Initial size was larger for tumors demonstrating early growth compared with those with delayed growth. For tumors within the IAC, those with early growth had a significantly higher median growth rate than those with delayed growth (1.40 vs. 0.45 mm/yr, p < 0.001). Conclusions: Delayed growth encompassed 8.1% of growing VSs and 3.9% of all observed tumors. Patients with delayed growth exhibited slower growth rates compared with those who were diagnosed with growth early in their observation course. These findings support the need for lifelong surveillance of untreated VSs given the possibility of clinically significant delayed growth. Increasing the time interval between MRI studies after 5 years is a reasonable concession to balance practicalities of cost and convenience with risk of delayed of tumor growth.
Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium
Miyagawa, Toji , Brushaber, Danielle , Syrjanen, Jeremy A. , Kremers, Walter K. , Fields, Julie A. , Forsberg, Leah K. , Heuer, Hilary W. , Kornak, John , Boxer, Adam L. , Rosen, Howie, McKinley, Emily , Padmanabhan, Jaya , Kremers, Walter K , Knopman, David S. , Boeve, Bradley F.

Mayo Clinic

Alzheimer's & Dementia | August 30, 2019 | Volume: 16 | Issue: 1 | Pages: 79-90

10.1016/j.jalz.2019.05.013 | PMID 31477517 Get It

AbstractIntroductionBehavior/Comportment/Personality (BEHAV) and Language (LANG) domains were added to the Clinical Dementia Rating (CDR®) for improving evaluation of patients with frontotemporal lobar degeneration (FTLD) (CDR® plus NACC FTLD).MethodsWe analyzed the CDR® plus NACC FTLD among participants from the baseline visit of the Advancing Research and Treatment for Frontotemporal Lobar Degeneration/Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects Consortium.ResultsThe CDR® plus NACC FTLD was able to detect early symptoms in the mildly impaired participants who were rated as CDR® sum of boxes (CDR®‐SB) = 0. The CDR®‐SB was not sensitive, particularly in participants with mild nonfluent/agrammatic primary progressive aphasia. Participants with familial and sporadic behavioral variant FTD exhibited similar CDR® plus NACC FTLD profiles except that language impairment was more frequent in participants with mild sporadic behavioral variant FTD. Adding the BEHAV and/or LANG domains to the CDR®‐SB significantly enhanced discriminatory power in differentiating among the FTLD spectrum disorders.DiscussionThe BEHAV and LANG domains enable the CDR® plus NACC FTLD to capture early symptomatology of FTLD.
Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1
Üstün, Celalettin , Kim, Soyoung , Chen, Min , Beitinjaneh, Amer , Brown, Valerie I. , Daly, Andrew , Freytes, César O. , Ganguly, Siddhartha , Hashmi, Shahrukh K. , Hildebrandt, Gerhard , Olsson, Richard F. , Page, Kristin , Saad, Ayman , Seo, Sachiko , William, Basem M. , Wirk, Baldeep , Auletta, Jeffery J. , Lindemans, Caroline A. , Riches, Marcie , Freytes, Cesar O , Hashmi, Shahrukh K , Hildebrandt, Gerhard C , Lazarus, Hillard M , Nishihori, Taiga , Olsson, Richard F , Saad, Ayman , Yared, Jean A , Komanduri, Krishna V , Riches, Marcie L , William, Basem , Dahi, Parastoo B , Díaz, Miguel Ángel , Lazarus, Hillard M. , Nishihori, Taiga , Papanicolaou, Genovefa A. , Wingard, John R. , Yared, Jean A. , Perales, Miguel‐Angel , Komanduri, Krishna V. , Auletta, Jeffery J , Kim, Soyoung

Mayo Clinic

Blood Advances | August 30, 2019 | Volume: 3 | Issue: 17 | Pages: 2525-2536

10.1182/bloodadvances.2019000226 | PMID 31471322 Get It

Abstract Presumably, reduced-intensity/nonmyeloablative conditioning (RIC/NMA) for allogeneic hematopoietic cell transplantation (alloHCT) results in reduced infections compared with myeloablative conditioning (MAC) regimens; however, published evidence is limited. In this Center for International Blood and Marrow Transplant Research study, 1755 patients (aged ≥40 years) with acute myeloid leukemia in first complete remission were evaluated for infections occurring within 100 days after T-cell replete alloHCT. Patients receiving RIC/NMA (n = 777) compared with those receiving MAC (n = 978) were older and underwent transplantation more recently; however, the groups were similar regarding Karnofsky performance score, HCT–comorbidity index, and cytogenetic risk. One or more infections occurred in 1045 (59.5%) patients (MAC, 595 [61%]; RIC/NMA, 450 [58%]; P = .21) by day 100. The median time to initial infection after MAC conditioning occurred earlier (MAC, 15 days [range, &lt;1-99 days]; RIC/NMA, 21 days [range, &lt;1-100 days]; P &lt; .001). Patients receiving MAC were more likely to experience at least 1 bacterial infection by day 100 (MAC, 46% [95% confidence interval (CI), 43-49]; RIC/NMA, 37% [95% CI, 34-41]; P = .0004), whereas at least a single viral infection was more prevalent in the RIC/NMA cohort (MAC, 34% [95% CI, 31-37]; RIC/NMA, 39% [95% CI, 36-42]; P = .046). MAC remained a risk factor for bacterial infections in multivariable analysis (relative risk, 1.44; 95% CI, 1.23-1.67; P &lt; .0001). Moreover, the rate of any infection per patient-days at risk in the first 100 days (infection density) after alloHCT was greater for the MAC cohort (1.21; 95% CI, 1.11-1.32; P &lt; .0001). RIC/NMA was associated with reduced infections, especially bacterial infections, in the first 100 days after alloHCT.
ESRA19-0430 Latex DYE confirmation of local anesthetic spread in pericapsular nerve group (PENG) block
Hall, Jason, Clendenen, Steven R.

Mayo Clinic

E-Poster Viewing Abstracts | August 30, 2019 | Volume: No volume available | Issue: No issue available | Pages: A213.2-A214

10.1136/rapm-2019-esraabs2019.371 Get It

ESRA19-0542 3d computed tomography reconstruction to optimize central neuraxial block trajectory in patients with degenerative spine disease
Riutort, Kevin T. , Clendenen, Steven R.

Mayo Clinic

E-Poster Viewing Abstracts | August 30, 2019 | Volume: No volume available | Issue: No issue available | Pages: A164-A165

10.1136/rapm-2019-esraabs2019.249 Get It

ESRA19-0401 Ultrasound-guided paravertebral catheter placement in a severe scoliosis patient undergoing robotic vats: a case report
Warfield, Dickens, Clendenen, Steven R. , Warfield, D

Mayo Clinic

E-Poster Viewing Abstracts | August 30, 2019 | Volume: No volume available | Issue: No issue available | Pages: A157.2-A158

10.1136/rapm-2019-esraabs2019.235 Get It

A conditional mouse model of complex II deficiency manifesting as Leigh‐like syndrome
Khazal, Fatimah Al, Holte, Molly Nelson, White, Thomas A. , LeBrasseur, Nathan, Iii, L James Maher, Bolon, Brad , White, Thomas A., LeBrasseur, Nathan K. , III, Louis James Maher

Mayo Clinic

The FASEB Journal | August 30, 2019 | Volume: 33 | Issue: 12 | Pages: 13189-13201

10.1096/fj.201802655rr | PMID 31469588 Get It

Leigh syndrome embodies degenerative disorders with a collection of symptoms secondary to inborn errors of metabolism. Combinations of hypomorphic and loss‐of‐function alleles in many genes have been shown to result in Leigh syndrome. Interestingly, deficiency for the tricarboxylic acid cycle enzyme succinate dehydrogenase (SDH) can lead to Leigh‐like syndrome in some circumstances and to cancer (paraganglioma, renal cell carcinoma, gastrointestinal stromal tumor) in others. In our experiments originally intended to create an inducible whole‐body SDH‐loss mouse model of tumorigenesis, we generated a condition reminiscent of Leigh‐like syndrome that is lethal to mice within 4 wk. Remarkably, as has been shown for other mitochondrial diseases, chronic hypoxia offers substantial protection to mice from this condition after systemic SDH loss, allowing survival in the context of profoundly impaired oxidative metabolism.—Al Khazal, F., Holte, M. N., Bolon, B., White, T. A., LeBrasseur, N., Maher, L. J. III. A conditional mouse model of complex II deficiency manifesting as Leigh‐like syndrome. FASEB J. 33, 13189–13201 (2019). www.fasebj.org
The Component Structure of the Dizziness Handicap Inventory (DHI): A Reappraisal
Wyngaerde, Kelly M. Van De, Lee, Minji K. , Jacobson, Gary P. , McCaslin, Devin L. , Wyngaerde, Kelly Van De, Pasupathy, Kalyan S. , Romero‐Brufau, Santiago

Mayo Clinic

Otology & Neurotology | August 30, 2019 | Volume: 40 | Issue: 9 | Pages: 1217-1223

10.1097/mao.0000000000002365 | PMID 31469793 Get It

Objective.: The Dizziness Handicap Inventory (DHI) is a 25-item self-report questionnaire developed to measure the disabling and handicapping impact of dizziness. The present investigation was conducted in an effort to re-assess the factor structure of the DHI. Study Design.: Retrospective study. Setting.: Tertiary care center. Patients.: Subjects were 1,991 patients who were evaluated in the Mayo Clinic-Rochester Vestibular and Balance Laboratory. Main Outcome Measures.: Exploratory factor analysis: an exploratory bifactor analysis (EFA) with bifactor rotation was used to analyze a random sample of 999 patients. Analyses were used to determine the dominance of the general factor (i.e., total score) relative to the group factor (i.e., subscales). Confirmatory factor analysis: a confirmatory bifactor graded response model was fit with appropriate item-to-group relationships that was discovered by our exploratory analyses. To validate the bifactor model that was identified with the exploratory analyses, a bifactor model with three grouping factors (i.e., Physical manifestations, Catastrophic impact of dizziness, and the Emotional impact of dizziness) were fit to a different random sample of 992 patients using the new item-to-group factor specifications. Results.: In the confirmatory analyses, all items had a positive factor loading on the general factor. There were 14 items that loaded on the general factor only. The rest of the items (n = 11) loaded on both the general factor and one of three group factors. Conclusions.: Conclusions of the study revealed several findings: 1) reporting the result as a total score (i.e., a single general factor) is warranted, and, 2) there is statistical support for the existence of three subscales representing: the Physical manifestations, Catastrophic impact, and Emotional impact of dizziness and vertigo.
Gene Expression and Missplicing in the Corneal Endothelium of Patients With a TCF4 Trinucleotide Repeat Expansion Without Fuchs' Endothelial Corneal Dystrophy
Wieben, Eric D. , Baratz, Keith H. , Aleff, Ross A., Maguire, Leo J., Fautsch, Michael P. , Kalari, Krishna R. , Tang, Xiaojia , Patel, Sanjay V.

Mayo Clinic

Investigative Opthalmology & Visual Science | August 30, 2019 | Volume: 60 | Issue: 10 | Pages: 3636

10.1167/iovs.19-27689 | PMID 31469403 Get It